Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP (IRMD) reports on the results of the Annual Meeting of Stockholders held on June 19, 2025. The report was filed on June 23, 2025, pursuant to Item 5.07 regarding the submission of matters to a vote of security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused solely on corporate governance voting outcomes and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document details the successful ratification of the company's independent auditor and the election of directors, which are standard governance events rather than financial shifts.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks and contingencies. The content is limited to the tabulation of votes for three specific proposals:
- Proposal 1 (Election of Directors): Stockholders elected Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel, and James Hawkins to the Board of Directors. All nominees received a majority of votes cast.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proposal 3 (Executive Compensation): Stockholders approved the advisory resolution on the compensation of named executive officers.
Important Facts for Investor Verification
- Verify the tenure of the newly elected directors, who serve until the next annual meeting or until a successor is elected.
- Confirm that RSM US LLP is the designated auditor for the fiscal year ending December 31, 2025.
- Note that the "Votes Against" for the executive compensation advisory vote were 286,889, representing a small minority of the total votes cast.
- Review the company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K does not contain them.